ORGANON & CO (OGN:NYSE)
$13.74 -0.01 (-0.0727%)
Analysed ORGANON & CO (OGN:NYSE) News Sources
The Surprising Pockmarks On Cooper's Earnings That Caused Its Stock To Dive
10-09-2026
yahoo.com
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
01-09-2026
yahoo.com
PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor
16-09-2026
yahoo.com
Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device
22-09-2026
yahoo.com
Why Organon (OGN) Is Getting Attention Today
22-09-2026
yahoo.com
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
01-10-2026
yahoo.com
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
14-10-2026
yahoo.com
Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting
16-10-2026
yahoo.com
Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
19-10-2026
yahoo.com
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
26-10-2026
yahoo.com
What is the current price of ORGANON & CO (OGN:NYSE)?
The current price of ORGANON & CO (OGN:NYSE) is $13.74.
ORGANON & CO (OGN:NYSE) absolute price change since previous trading day?
The absolute price change of ORGANON & CO (OGN:NYSE) since the previous trading day is $-0.01.
ORGANON & CO (OGN:NYSE) percentage price change since previous trading day?
The percentage price change of ORGANON & CO (OGN:NYSE) since the previous trading day is -0.0727%.
What is the most recent average sentiment score for ORGANON & CO (OGN:NYSE)?
The most recent average sentiment score for ORGANON & CO (OGN:NYSE) is 62 out of 100.
What is the most recent average sentiment for ORGANON & CO (OGN:NYSE)?
The most recent sentiment for ORGANON & CO (OGN:NYSE) is .
SEC-8K** Filing Available For ORGANON & CO (OGN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.